Krystal Biotech Inc (KRYS)
Debt-to-equity ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 778,641 | 522,231 | 593,576 | 292,084 | 202,914 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $778,641K
= 0.00
Krystal Biotech Inc has consistently maintained a debt-to-equity ratio of 0.00 across the years 2019 to 2023. This indicates that the company has been financing its operations primarily through equity rather than debt. A debt-to-equity ratio of 0.00 means that the company has no debt in its capital structure or that its level of debt is negligible compared to its equity. This low ratio suggests that the company may have a strong financial position and may be less risky for investors and creditors, as there is minimal financial leverage. However, it is also important to consider other financial metrics and factors to obtain a comprehensive assessment of Krystal Biotech Inc's financial health and performance.
Peer comparison
Dec 31, 2023